SILICON VALLEY, Calif., March 26, 2018 -- Cloud based medical office platform PracticeSuite announced today it has achieved Stage 3 Meaningful Use certification of its electronic health record (EHR) software for general medicine and a number of health specialties through InfoGard, an ONC-authorized certification body (ONC-ACB).
This certification places PracticeSuite among 23 elite healthcare software companies that offer Stage III Meaningful Use certification with Clinical Quality Measures and DirectTrust® project certification, which are key requirements to qualify for Medicare's Merit Based Incentive Payments System (MIPS) under MACRA. The list of ONC Certified EHR products is down from 4000 Stage II products, to fewer than 300 Stage III certified products.
“PracticeSuite is emerging as a true cloud healthcare platform for outpatient care," states its CEO Vinod Nair. "But moving forward, it is imperative that physicians select a one stop solution and eliminate multiple technology vendors in order to stay ahead of cost, compliance, and care requirements."
"PracticeSuite’s Cloud Platform offers the ability to Care, Collect, Connect, Collaborate, build Credibility, prevent Cyberattacks, and remain Compliant,” states Mr. Nair. “PracticeSuite is looking out for the needs of its client beyond the horizon.”
About PracticeSuite, Inc.
PracticeSuite is a Silicon Valley cloud computing platform for outpatient care that provides end-to-end medical office solutions. It serves 155 billing specialties and 61 clinical specialties, and over 41,000 clinical professionals use its system to serve their patients. Platform features include clinical and practice management software, revenue cycle management services, and the required interoperability to comply with Medicare's Merit Based Incentive Payments System (MIPS) under MACRA––Medicare's Access and CHIP Reauthorization Act of 2015. PracticeSuite is also at the forefront of concierge healthcare, providing doctors the technology required to practice subscription based, direct care primary medicine.
Michael Sculley Phone Number: 770-213-4723 Email: [email protected]


BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Apple Restores Telegram to App Store After Content Policy Violation
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 



